Integrative Analysis of Cancer Omics Data for Prognosis Modeling

scientific article published on 09 August 2019

Integrative Analysis of Cancer Omics Data for Prognosis Modeling is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/GENES10080604
P932PMC publication ID6727084
P698PubMed publication ID31405076

P2093author name stringShuangge Ma
Mengyun Wu
Shuaichao Wang
P2860cites workIdentification of DBC1 as a transcriptional repressor for BRCA1Q24299659
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccinationQ24652965
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progressionQ26800112
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancerQ27851654
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancerQ27851720
Cancer genes and the pathways they controlQ28275089
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortalQ28288215
Gamma-secretase composed of PS1/Pen2/Aph1a can cleave notch and amyloid precursor protein in the absence of nicastrinQ28595013
Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis.Q31089944
EGFR and cancer prognosisQ34399312
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexesQ34667055
The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinomaQ35105594
Risk Factors of Non-Hodgkin LymphomaQ35499320
survcomp: an R/Bioconductor package for performance assessment and comparison of survival modelsQ35526651
Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's diseaseQ35592787
Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer.Q35632227
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.Q35643852
ETV6: a versatile player in leukemogenesis.Q36096564
PD-1 and BTLA and CD8(+) T-cell "exhaustion" in cancer: "Exercising" an alternative viewpointQ36194853
DBC1/CCAR2 is involved in the stabilization of androgen receptor and the progression of osteosarcomaQ36273633
ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complexQ36328085
Clinical significance of tumor-infiltrating immune cells focusing on BTLA and Cbl-b in patients with gallbladder cancerQ36467408
Annexin A1, A2, A4 and A5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergisticallyQ36475757
NOTCH signaling as a novel cancer therapeutic targetQ36539533
Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancerQ36616070
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomesQ36777326
A novel crosstalk between CCAR2 and AKT pathway in the regulation of cancer cell proliferationQ37603343
Targeting notch signaling pathway in cancer: clinical development advances and challengesQ37696748
Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancerQ37877648
Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia.Q39120062
NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells.Q40284301
AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancerQ40305921
EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.Q40634600
Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithmQ41557019
Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang ProvinceQ45025590
The pan-cancer analysis of gene expression patterns in the context of inflammationQ45733279
Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasis.Q45985228
Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis.Q47204660
Investigation of model stacking for drug sensitivity prediction.Q51733516
Regularized estimation in the accelerated failure time model with high-dimensional covariates.Q51933180
Dissecting the sources of gene expression variation in a pan-cancer analysis identifies novel regulatory mutations.Q52315593
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.Q52602405
CCAR2 deficiency augments genotoxic stress-induced apoptosis in the presence of melatonin in non-small cell lung cancer cells.Q53030141
PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.Q53486364
Simultaneous prediction of multiple outcomes using revised stacking algorithmsQ91536176
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue8
P577publication date2019-08-09
P1433published inGenesQ5532699
P1476titleIntegrative Analysis of Cancer Omics Data for Prognosis Modeling
P478volume10

Reverse relations

Q92153663Knowledge Generation with Rule Induction in Cancer Omicscites workP2860

Search more.